CEFTRIAXONE ALVOGEN POWDER FOR SOLUTION FOR INJECTION INFUSION 1GVIAL

国家: 新加坡

语言: 英文

来源: HSA (Health Sciences Authority)

有效成分:

Ceftriaxone Sodium 1.079g eqv to Ceftriaxone

可用日期:

LOTUS INTERNATIONAL PTE. LTD.

ATC代码:

J01DD04

剂量:

1.0 g

药物剂型:

INJECTION, POWDER, FOR SOLUTION

组成:

Ceftriaxone Sodium 1.079g eqv to Ceftriaxone 1.0 g

给药途径:

INTRAVENOUS, INTRAMUSCULAR

处方类型:

Prescription Only

厂商:

Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd

授权状态:

ACTIVE

授权日期:

2014-11-20

产品特点

1
Package Insert
_ _
1.
NAME OF THE MEDICINAL PRODUCT
CEFTRIAXONE ALVOGEN POWDER FOR SOLUTION FOR INJECTION/ INFUSION
1G/VIAL
CEFTRIAXONE ALVOGEN POWDER FOR SOLUTION FOR INJECTION/ INFUSION
2G/VIAL
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial contains 1 g ceftriaxone (as ceftriaxone sodium).
Each vial contains 2 g ceftriaxone (as ceftriaxone sodium).
3.
PHARMACEUTICAL FORM
Powder for solution for injection/infusion.
Almost white or yellowish, slightly hygroscopic, crystalline powder.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ceftriaxone is indicated for the treatment of the following infections
when known or likely to be due
to one or more susceptible micro-organisms (see section 5.1) and when
parenteral therapy is required:
-
Pneumonia.
-
Sepsis.
-
Meningitis.
-
Bone, skin and soft tissue infections.
-
Infections in neutropenic patients.
-
Gonorrhoea.
-
Peri-operative prophylaxis of infections.
Treatment may be started before the results of susceptibility tests
are known.
Consideration should be given to official guidance on the appropriate
use of antibacterials.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
CEFTRIAXONE ALVOGEN may be administered by intramuscular injection,
intravenous injection,
or as intravenous infusion, after reconstitution of the solution
according to the directions given below.
Do not use diluents containing calcium, such as Ringer’s solution or
Hartmann’s solution, to
reconstitute ceftriaxone vials or to further dilute a reconstituted
vial for IV administration because a
precipitate can form. Precipitation of ceftriaxone-calcium can also
occur when ceftriaxone is mixed
with calcium-containing solutions in the same IV administration line.
Ceftriaxone must not be
administered simultaneously with calcium-containing IV solutions,
including continuous calcium-
containing infusions such as parenteral nutrition via a Y-site.
However, in patients other than
neonates, ceftriaxone and calcium-containing solutions may be
administered sequentially of one
another if the in